Transplantation of pancreatic islets

Area of Science:

• Biomedical Engineering
• Transplantation Immunology
• Endocrinology

Background:

• Limited supply of human pancreatic islets necessitates alternative sources for diabetes treatment.
• Current limitations in islet isolation require multiple glands per patient, highlighting the need for refined xenografting techniques.

Purpose of the Study:

• To evaluate the efficacy of immunoisolation techniques for xenografting animal islets into diabetic patients.
• To explore the potential of biodegradable polymer-based microreactors for injectable islet transplantation.

Main Methods:

• Testing various immunoisolation devices, including arteriovenous (AV) shunts, tubular membrane chambers, and micro/macrocapsules in animal models.
• Utilizing selectively permeable membranes and matrix supports for cell encapsulation.
• Fabricating injectable microreactors from biodegradable polymers.

Main Results:

• Immunoisolation systems demonstrated successful islet function in diabetic animals for extended periods (months to over a year).
• Transplantation across species barriers was achieved without the need for immunosuppression.
• Injectable microreactors showed potential for practical application.

Conclusions:

• Immunoisolation technology offers a viable strategy for overcoming the limitations of human islet supply in diabetes therapy.
• Biodegradable polymer-based microreactors represent a promising advancement for injectable islet transplantation.
• This approach has the potential to revolutionize the treatment of diabetes and other human diseases through cell and tissue transplantation.